Publications by authors named "Joe O Sullivan"

Claim this Profile
U
UK real-world data of radium-223 dichloride in metastatic prostate cancer.
Manreet Randhawa, Gail Buchanan, Irene M Stratton, Gemma Race, Amar Challapalli, Joe M O'Sullivan

Nucl Med Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of image-guided in vivo irradiation on voiding patterns and bladder contractility in female mice.
Sarah McDowell, Conor Breen, Niamh McKerr, Kirtiman Srivastava, Daniel Crummey, Joe M O'Sullivan

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and Challenges.
Neal D Shore, Stephen J Freedland, Lisa G Horvath, Joe M O'Sullivan, Ugo De Giorgi

Eur Urol Focus· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Large-scale Digital Survey of Patients with Localized and Advanced Prostate Cancer in Germany, the UK, and the USA.
Joe M O'Sullivan, Brian D Gonzalez, Lisa M Gudenkauf, Axel Heidenreich, Stephen Allen

Eur Urol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of rectum contours generated by artificial intelligence automatic contouring software using geometry, dosimetry and predicted toxicity.
Owen McLaughlin, Fereshteh Gholami, Sarah Osman, Joe M O'Sullivan, Stephen J McMahon

Biomed Phys Eng Express· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial.
Catarina R Palma Dos Reis, Joe O'Sullivan, Eric O Ohuma, Tim James, Aris T Papageorghiou

Am J Obstet Gynecol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study.
Joe M O'Sullivan, Daniel Heinrich, Elena Castro, Saby George, Sabina Dizdarevic

Br J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
Silke Gillessen, Fabio Turco, Ian D Davis, Jason A Efstathiou, Karim Fizazi, Joe M O'Sullivan

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Gianmarco Leone, Francesco Orlando, Peter Dutey-Magni, Osvaldas Vainauskas, Emily Grist, Joe M O'Sullivan

JAMA Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic castration-resistant prostate cancer: review of current evidence and synthesis of expert opinions on radioligand therapy.
Darren M C Poon, William S K Cheung, Peter K F Chiu, Daniel H S Chung, John B T Kung, Joe M O'Sullivan

Front Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus.
Thomas A Harding, Richard M Martin, Samuel Wd Merriel, Robert Jones, Joe M O'Sullivan

Br J Gen Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial.
Timothy L Jackson, Riti Desai, Hatem A Wafa, Yanzhong Wang, Janet Peacock, Joe M O'Sullivan

Lancet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer.
Victoria L Dunne, Timothy C Wright, Francisco D C Guerra Liberal, Joe M O'Sullivan, Kevin M Prise

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An objective measure of response on whole-body MRI in metastatic hormone sensitive prostate cancer treated with androgen deprivation therapy, external beam radiotherapy, and radium-223.
Valentina Giacometti, Arthur C Grey, Aaron J McCann, Kevin M Prise, Alan R Hounsell, Joe M O'Sullivan

Br J Radiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
Daniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, Alberto Briganti, Irene A Burger, Joe M O'Sullivan

Eur Urol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Feasibility Trial of Stereotactic Prostate Radiation Therapy With or Without Elective Nodal Irradiation in High-Risk Localized Prostate Cancer (SPORT Trial).
Orla A Houlihan, Kelly Redmond, Ciaran Fairmichael, Ciara A Lyons, Conor K McGarry, Joe M O'Sullivan

Int J Radiat Oncol Biol Phys· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound targeted microbubble destruction using docetaxel and Rose Bengal loaded Microbubbles for targeted Chemo-Sonodynamic therapy treatment of prostate cancer.
Thomas McKaig, Keiran Logan, Heather Nesbitt, Bridgeen Callan, Stephanie McKeown, Joe M O'Sullivan

Eur J Pharm Biopharm· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT).
Malcolm Brown, Marie H Murphy, Helen McAneney, Ken McBride, Ffiona Crawford, Joe M O'Sullivan

Support Care Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating radium-223 therapy into the management of metastatic prostate cancer care: a plain language summary.
Joe M O'Sullivan, Elliot Abramowitz, Len Sierra-Scacalossi

Future Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
Silke Gillessen, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi, Joe M O'Sullivan

Eur J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Gerhardt Attard, Laura Murphy, Noel W Clarke, Ashwin Sachdeva, Craig Jones, Joe M O'Sullivan

Lancet Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
Silke Gillessen, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi, Joe M O'Sullivan

Eur Urol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer.
Joe M O'Sullivan, Rana R McKay, Kambiz Rahbar, Karim Fizazi, Daniel J George

Front Med (Lausanne)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
Nicholas D James, Fiona C Ingleby, Noel W Clarke, Claire L Amos, Gerhardt Attard, Joe M O'Sullivan

JNCI Cancer Spectr· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential responses to Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe.
Francisco D C Guerra Liberal, Hugo Moreira, Kelly M Redmond, Joe M O'Sullivan, Ali H D Alshehri

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis